The Food and Drug Administration has revoked use of the synthetic dye Red No. 3 -- approved to provide color in food and ...
20h
Biosimilars have been on the market in Europe since 2007 but have had a larger impact on Amgen since 2019 as US exposure intensifies. Pressure on Prolia/Xgeva is coming in 2025. Amgen's pipeline had ...
A Rockville immunotherapy company struck an $8 million deal to take back ownership of the drug candidates it’s been licensing ...
D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...
Cognitively normal human brain samples collected at autopsy in early 2024 contained more tiny shards of plastic than samples ...
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word (s): AGM/EGM SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items 04.02.2025 / 18:22 CET/CEST The issuer is ...
Every year, US dairy producers churn out billions of pounds of cheese—over 14 billion in 2023 alone. As that cheese heads to ...
One day after signing executive orders to impose 25% tariffs on goods from Mexico and Canada, and 10% on Chinese items, ...
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
Robert F. Kennedy Jr. sounded concern on the GRAS process and claimed GLP-1s are “miracle drugs” but fell short on the drugs ...
On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest gratitude ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback